Tratamento
Understanding the difference between synthetic, biological, and generic semaglutide helps patients make informed decisions about their treatment options and potential cost savings.
The high demand for tirzepatide has created a lucrative black market at the border. Learn why patients risk smuggling and what dangers they face.
Considering switching from Ozempic to Mounjaro? Learn the key differences in how they work, dosing schedules, effectiveness, and what to discuss with your doctor.
Restaurant dining presents unique challenges for patients on GLP-1 weight loss medications due to their appetite-suppressing effects and food preference changes.
Many patients wonder if they can get back on track after stopping semaglutide. Here's what the research and doctors say about restarting GLP-1 treatment.
Brazil's ANVISA just approved a second generic semaglutide, opening the door to more competition and potentially lower prices for GLP-1 medications. Here's what to expect.
Eurofarma announced a significant price reduction for its semaglutide treatment Poviztra, potentially expanding access to GLP-1 therapy for Brazilian patients who previously faced high costs.
Brazil now has its own semaglutide injection made on national soil. Learn how Ozivy works, what makes it different from existing options, and what it could mean for access to GLP-1 therapies in the country.
Can temperature fluctuations ruin your GLP-1 weight loss pen during long trips? Here's what the stability data says about storing Ozempic, Mounjaro, and similar medications while traveling.
Brazil's medical council issued guidance targeting compounded GLP-1 drugs for weight loss. Here's what patients and doctors need to understand about the controversy.
